Yuhan provides Leclaza with 6 million won per month for free
By Kim, Jin-Gu | translator Kim, Jung-Ju
23.07.10 17:36:00
°¡³ª´Ù¶ó
0
Yuhan Corporation runs a EAP until the first treatment benefits apply
There was no fair competition problem even in the second treatment
When the benefit is applied, EAP is terminated, and patients must pay for it
¡ãLeclaza
Regarding Yuhan's providing free medicines to patients until the first treatment of Leclaza is covered by insurance, Yuhan said, "It is not an act of inducing patients and there is no problem under the Fair Trade Act."On the 10th, Yuhan held a press conference for permission for the first treatment of Leclaza at the Plaza Hotel in Seoul. On this day, CEO Cho Wook-je announced the free supply of Leclaza through the Expanded Access Program. Yuhan Corporation launches large-scale 'EAP' for the first time as a domestic pharmaceutical company
EAP is a humanitarian system that provides treatment opportunities by supplying new drugs free of charge to patients who do not have adequate treatment
Kim, Jin-Gu(kjg@dailypharm.com)
If you want to see the full article, please JOIN US (click)